drugset / Trial / NCT06153758

Study to Learn How Different Forms of The Study Medicine Called Danuglipron Are Taken up Into the Blood In Healthy Adults

NCT06153758

Phase 1 Completed 33 enrolled Pfizer
Non-randomizedCrossoverOpen-labelBasic science

Summary

The purpose of the study is to learn how different forms of a study medication called danuglipron are taken into the blood in healthy adults, following single dose administration.

Timeline

Start
2023-11-27
Primary completion
2024-09-30
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Danuglipron Small molecule Oral

Indications

No indication recorded.